On Feb. 21, 2022, China NMPA issued the Management of Cosmetic Adverse Reaction Monitoring, which is China's first regulation specifically for the management of cosmetic adverse reaction monitoring.
It consists of 7 chapters and 47 articles, as shown shown as follows:
Chapter I General Provisions
Chapter II Responsibilities and Obligations
Chapter III Adverse Reaction Reporting
Chapter IV Analysis and Evaluation of Adverse Reactions
Chapter V Adverse Reaction Investigation
Chapter VI Supervision and Management
Chapter VII Supplementary Provisions
Original regulatory document
